Healthcare provider profile · identity verified

Shylasree Krishnan, M.D.

Internal Medicine · ROCHESTER, NY · NPI 1023048543

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	626	189
Amlodipine Besylate	Amlodipine Besylate	373	97
Rosuvastatin Calcium	Rosuvastatin Calcium	342	117
Hydrochlorothiazide	Hydrochlorothiazide	313	78
Levothyroxine Sodium	Levothyroxine Sodium	286	84
Lisinopril	Lisinopril	280	76
Omeprazole	Omeprazole	250	71
Gabapentin	Gabapentin	249	57
Famotidine	Famotidine	225	58
Metoprolol Succinate	Metoprolol Succinate	178	43
Metformin Hcl	Metformin Hcl	146	41
Pantoprazole Sodium	Pantoprazole Sodium	143	44
Losartan Potassium	Losartan Potassium	142	47
Escitalopram Oxalate	Escitalopram Oxalate	139	31
Fluticasone Propionate	Fluticasone Propionate	138	52
Metformin Hcl Er	Metformin Hcl	120	28
Alendronate Sodium	Alendronate Sodium	116	36
Montelukast Sodium	Montelukast Sodium	113	30
Duloxetine Hcl	Duloxetine Hcl	109	24
Albuterol Sulfate Hfa	Albuterol Sulfate	97	41
Ozempic	Semaglutide	91	12
Tamsulosin Hcl	Tamsulosin Hcl	80	23
Eliquis	Apixaban	77	15
Chlorthalidone	Chlorthalidone	76	24
Zolpidem Tartrate	Zolpidem Tartrate	76	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	18
Meloxicam	Meloxicam	72	22
Allopurinol	Allopurinol	69	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	15
Clonazepam	Clonazepam	65	14
Potassium Chloride	Potassium Chloride	63	12
Fenofibrate	Fenofibrate	62	13
Trazodone Hcl	Trazodone Hcl	61	15
Alprazolam	Alprazolam	59	21
Bupropion Xl	Bupropion Hcl	58	11
Simvastatin	Simvastatin	58	18
Furosemide	Furosemide	56	19
Warfarin Sodium	Warfarin Sodium	56	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	16
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Trulicity	Dulaglutide	51	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	15
Pregabalin	Pregabalin	45	11
Spironolactone	Spironolactone	45	13
Carvedilol	Carvedilol	44	15
Citalopram Hbr	Citalopram Hydrobromide	44	14
Pravastatin Sodium	Pravastatin Sodium	42	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	18
Mirtazapine	Mirtazapine	40	suppressed
Buspirone Hcl	Buspirone Hcl	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Sertraline Hcl	Sertraline Hcl	39	13
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	14
Jardiance	Empagliflozin	36	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	35	35
Torsemide	Torsemide	34	12
Atenolol	Atenolol	33	11
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Rizatriptan	Rizatriptan Benzoate	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Ketoconazole	Ketoconazole	24	14
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Felodipine Er	Felodipine	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Cephalexin	Cephalexin	19	16
Irbesartan	Irbesartan	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Topiramate	Topiramate	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Valsartan	Valsartan	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Linzess	Linaclotide	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Valacyclovir	Valacyclovir Hcl	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Acyclovir	Acyclovir	13	suppressed
Baclofen	Baclofen	13	suppressed
Diazepam	Diazepam	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Finasteride	Finasteride	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Digoxin	Digoxin	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	11
Glimepiride	Glimepiride	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ramipril	Ramipril	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error